Physicians, scientists, doctoral researchers and technical staff – click a person for a short profile.
Lorenz is a clinician scientist focusing on cardiac epigenetics, cardiac metabolism and clinical cardio-oncology. His interest lies in the co-morbidities of cardiac disease. He leads the Cardio-Oncology group in Heidelberg and its specialist outpatient clinic. The group aims to answer clinical questions using preclinical models.
Jannek is a clinician scientist focusing on preclinical genetic models to study immune checkpoints in cardiac cells and their effects on misguided immune responses. He is also interested in the cardiac side effects of radiation in preclinical models.
Lukas works as a clinician scientist in cardiology and is interested in big-data analyses. He also develops prospective observational studies in cardio-oncology imaging and multiomics approaches in cardio-oncology patients.
Daniel is a clinician scientist focusing on epigenetic changes and transcriptional regulation in cardiomyocytes. His current projects address the epigenetic regulation of metabolic signaling, the control of histone deacetylases and anthracycline toxicity. In clinical research he is interested in identifying factors that predict future cardiac events in oncology patients.
Markus is a clinician scientist focusing on bioinformatics and cardiovascular phenotyping of preclinical models. His current projects investigate cardiac metabolic signaling in cancer and how pathological metabolism and remodeling can be visualized in patients. He is also interested in the molecular basis of ICI-associated myocarditis.
Christoph is a clinician scientist with expertise in analyzing large datasets. He specializes in unconventional interactions directly between oncological disease and cardiac processes, and vice versa.
Melis is a clinician scientist investigating the relationship between cancer disease/cancer therapy and the leading symptom of dyspnea, based on sarcopenia.
Benay is a PhD student with a strong interest in cancer- and cancer-therapy-dependent epigenetic changes and how modifying them can protect the heart. She studies the role of epigenetic modifiers and their translational potential.
Arshad studies immune checkpoints in cardiac vessels and molecular targets.He is specializst in developing screening platforms for compounds.
Vighnesh is a PhD student interested in the regulation of the epigenetic memory of specific gene regions. His focus is on CRISPR/Cas9-mediated approaches to identify proteomic interaction partners and manipulate them in vitro and in vivo.
Jan is a medical student investigating the clinical association between oncological diseases/therapies and arrhythmias.
Maike is a medical student investigating the value of cardiac biomarkers in oncology patients using registry data, and performs further analyses in preparation for prospective studies.
Vincent is a medical student with a talent for cloning and cell culture. His project investigates the interaction between metabolic signals in the heart muscle and cancer metastasis.
Pauline is a medical student with a translational project on the therapy of immune checkpoint inhibitor-associated myocarditis, collecting both clinical and preclinical data.
Alexander is a specialist in FRET assays and in vitro life cell imaging. He work on intracellular cardioprotective targets
Simon is a medical student investigating the interaction between thoracic radiotherapy and possible cardiovascular complications across patient cohorts.
Szanett is a medical doctoral researcher investigating the cardiotoxic effects of MCL-1 inhibitors in preclinical models.
Ezzedin is a medical doctoral researcher investigating the incidence and predictors of Cancer Therapy-Related Cardiac Dysfunction (CTRCD) in patients receiving HER2-antibody therapy.
Daniel investigates how enhancer-specific RNA can influence the condensation of proteins.
Viktoria is a medical student with extensive experience in primary cell culture (PBMCs, NRVMs). She is developing an in-vitro model of immune checkpoint inhibitor-associated myocarditis and studies how cardiomyocyte-specific downstream targets can be identified.
Isabel Santos is a medical student interested in the molecular mechanisms of anthracycline cardiotoxicity, studying the transcriptional processes and inflammation pathways.
Daniel is a medical doctoral researcher investigating the predictive value of clinical parameters and cardiac biomarkers for cardiological side effects of oncological therapies.
Frederike is a medical doctoral researcher investigating the prospective value of FAPI-PET-CT in oncology patients. She is currently recruiting patients for a prospective clinical study.
Jessica is a medical doctoral researcher investigating the role of acute coronary syndrome in cancer patients, focusing on the relationship between intervention and mortality in this group.
Christian is a medical student investigating associations between cardiac biomarkers and coronary artery disease in cardio-oncology patients using prospectively collected data.
Fynn is a medical student with a strong interest in cardiac metabolism. His project focuses on nuclear receptors and how they are regulated and regulate glucose metabolism. He is an expert in Co-IPs.
Belal is a medical student specializing in imaging in collaboration with nuclear medicine. His interest lies in visualizing cardio-metabolic changes in preclinical and clinical studies; he also studies the interaction of cancer and cardiac metabolism in humans.
Mikail is a medical student working intensively on the interaction of T cells and cardiomyocytes. He studies in vivo the effects of genetic changes on heart muscle cells.
Zhou is a medical student specializing in generating recombinant proteins and studying condensation processes.
Susanna is a medical student with expertise in organizing and analyzing large datasets. Her current project focuses on cardio-oncology questions in retrospective patient data from our clinic.
Ines organizes the outpatient clinic for cardio-oncology patients. As senior study nurse she manages the ongoing clinical studies (data collection, protocols, study administration). Thanks to her long experience in managing clinical studies she is our first contact when planning future clinical projects.
Dominic is a technician (MTA) in the lab and part of the organizational team. He supervises students and is responsible for primary cell culture and RNA- and protein-based analyses.
Jennifer is the organizational center of the preclinical team. As a trained technician (MTA) she is our contact for all standard molecular biology procedures. She is also interested in advancing the CRISPR-Cas9 system and establishes Cas9-based methods for proteomic screens.
Nils is a technician (MTA) and a pillar of the lab. He is a specialist in cell culture and RNA- and protein analyses and introduces students to the basics of laboratory research.